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We have previously shown that the administration of Camino-3,4-d-pyrazolopyrimidine (CAPP) to rats 
reduces progesterone synthesis by cells subsequently isolated from their corpora lutea, and that plasma high 
density lipoprotein (HDL) can restore this progesterone synthesis to normal. In this paper we demonstrate 
that a dispersion of phospholipid and cholesterol, but not other sterols, can enhance this 4-APP-disabled 
progesterone synthesis to the same level as can HDL, thus providing the first direct evidence that cholesterol 
is the component of HDL upon which rat corpus luteum depends for its ability to synthesize progesterone. 
Progesterone synthesis (Rat corpus luteum) 4-Amino-3,4-d-pyrazolopyrimidine 
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1. INTRODUCTION 
The administration of the plasma lipoprotein- 
lowering agent 4-APP to rats is known to reduce 
progesterone synthesis as estimated in vivo [ 1,2] or 
in vitro [3] and HDL administered in vivo [2,4] or 
presented to isolated corpus luteum cells in vitro 
[3] can restore this progesterone synthesis to nor- 
mal. From this evidence we have suggested that rat 
corpus luteum depends upon access to circulating 
HDL for its ability to synthesize progesterone [3]. 
However, it seems clear from a recent review [5] 
that the same evidence has been interpreted by 
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others as indicating that the rat corpus luteum 
depends upon circulating HDL cholesterol. 
Without direct experimental evidence it would 
seem unwise to assume that cholesterol must be the 
component of HDL that is involved in the 
mechanism by which HDL supports luteal pro- 
gesterone synthesis. Clearly, 4-APP does not cause 
selective lowering of plasma cholesterol evels, but 
rather a general lowering of plasma lipoprotein 
levels such that tissues are deprived of access to all 
of the components of the lipoproteins, not to 
cholesterol alone. Similarly, infusion of HDL in 
vivo or presentation of HDL to isolated cells ex- 
poses the cells to the entire HDL species and not 
just to cholesterol selectively. In theory, any com- 
ponent of HDL could be involved in supporting 
cellular steroid synthesis. 
Other evidence linking plasma cholesterol with 
progesterone synthesis is also indirect. The virtual 
equilibration of specific radioactivity between cir- 
culating progesterone, ovarian cholesterol and 
plasma cholesterol after administration of radioac- 
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tively labelled cholesterol or acetate [6-81 has been 
cited to support the view that steroid hormones are 
synthesized from cholesterol taken from the 
plasma [5] but because of the evidence that 
cholesterol exchange occurs between plasma 
lipoproteins and cells (reviewed in [9]), this cannot 
be taken to indicate the net uptake of cholesterol 
from plasma by tissues. 
A fall in the luteal content of cholesteryl ester is 
known to result from 4-APP treatment [1,3], but 
4-APP treatment does not change the amount of 
unesterified cholesterol in these cells which, even 
when depleted of cholesteryl esters, still contain 
unesterified cholesterol equivalent to over 
lOOO-times the amount of progesterone that they 
can synthesize when fully stimulated with lutropin 
and HDL [3]. Virtually nothing is known about the 
metabolic compartmentation of cholesterol or 
cholesteryl esters within the luteal cell, and the in- 
tracellular pool of sterol from which progesterone 
is synthesized has not been identified. Clearly, it 
would be wrong to argue that, because 4-APP 
treatment lowers luteal cell cholesteryl ester con- 
tent and also impairs luteal cellular progesterone 
synthesis, the impairment in progesterone syn- 
thesis must be due to the lowering of cellular 
cholesteryl esters. 
The mechanism by which HDL interacts with 
the luteal cell, although apparently different from 
the LDL-pathway, has not yet been defined [lo]. 
Fundamental to the investigation and under- 
standing of this mechanism is the question of 
which of its components HDL contributes to luteal 
progesterone synthesis. The present work was 
undertaken because of the indirectness of the 
evidence, presented above, on this point. By 
demonstrating that the low rate of progesterone 
synthesis in luteal cells derived from rats treated 
with 4-APP can be restored to normal by supply- 
ing them with cholesterol in non-lipoprotein form, 
this work provides the first direct evidence that the 
cholesterol component of HDL is involved in the 
mechanism by which HDL can support luteal pro- 
gesterone synthesis. 
2. MATERIALS AND METHODS 
The source of rats, methods for inducing 
superovulation, treatment with 4-APP, prepara- 
tion and incubation of isolated luteal cells and 
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assay of progesterone were as described [l 11. L-LY- 
Phosphatidylcholine (from egg yolk), ergosterol, 
&sitosterol and dihydrocholesterol were purchased 
from Sigma, Poole, England, and heparin-agarose 
was purchased from Pharmacia, Milton Keynes, 
England. Cholesterol was purified as described in 
[12]; this, and all other sterols used, were 
recrystallised before use [13]. All other chemicals 
were as previously listed [l 11. HDL was prepared 
as in [14], except that apoB-containing HDL was 
removed by chromatography on heparin-agarose 
[ 151. Lipid dispersions were prepared by sonicating 
3 mg L-cY-phosphatidylcholine and 2 mg sterol in 
1 ml buffer (2 mM sodium phosphate; 50 mM 
sodium chloride; pH 7.4) at low power and 
amplitude setting no. 1, in a 150 W ultrasonic 
disintegrator (type PG 100; MSE, Crawley, 
England) for 20 min. Delipidated HDL apopro- 
teins were prepared as in [ 161. When present in the 
incubations, lutropin was at 200 ng/ml and HDL 
at 0.8 mg HDL protein/ml, unless otherwise stated 
in the text, or in the legends to tables and figures. 
When phospholipid/sterol dispersions were pre- 
sent during incubations their concentrations were 
such as to provide 0.4 mg sterol/ml, unless other- 
wise indicated. 
3. RESULTS AND DISCUSSION 
The data in table 1 show that, under the condi- 
tions used, the phospholipid/cholesterol disper- 
sion stimulated luteal cellular progesterone forma- 
tion to virtually the same extent as did HDL. This 
effect of the phospholipid/cholesterol dispersion 
was saturable (fig.1). A double-reciprocal plot of 
the data shown in fig.1 (not shown) gave 
0.07 mg/ml as the concentration of cholesterol 
necessary for half-maximal stimulation of pro- 
gesterone synthesis. In experiments imilar to those 
described in fig.1, but using native rat HDL in- 
stead of the phospholipid/cholesterol dispersion, it 
was found that half-maximal stimulation of pro- 
gesterone synthesis occurred in the presence of 
0.13 mg HDL protein/ml [17]. From the known 
composition of rat HDL [ 181 this was equivalent o 
0.02 mg HDL cholesterol/ml or to 0.1 mg HDL 
total cholesterol (unesterified cholesterol + 
cholesteryl ester)/ml. In view of the uncertainty 
over whether or not the luteal cells might be able 
to utilise HDL cholesteryl esters or HDL 
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Table 1 
Effect of a phospholipid/cholesterol dispersion on 
progesterone synthesis by luteal cells isolated from rats 
treated with 4-APP 
Present during incubation Progesterone formed 
(ng/106 cells per 2 h) 
Lutropin 
Lutropin + phospholipid/ 
(a) (b) 
457 (36.1) 578 (19.1) 
cholesterol 1191 (94.2) 2793 (92.3) 
Lutropin + HDL 1264 (100) 3024 (100) 
Rats were treated with 4-APP and cells were prepared 
and incubated as described in section 2, where the 
procedures for assaying progesterone and for preparing 
HDL and phosphoiipid/cholesterol dispersions are also 
given. Lutropin was present at 200 ng/ml, HDL at 
0.8 mg/ml and phospholipid/cholesterol dispersion at 
0.4 mg cholesterol/ml. (a) and (b) refer to two separate 
experiments using different preparations of luteal cells. 
Numbers in parentheses are the % yields of progesterone 
in each experiment, relative to that produced in the 
presence of lutropin + HDL (100%) 
unesterified cholesterol or both, there appears to 
be reasonable agreement between the amounts of 
cholesterol required for half-maximal stimulation 
of luteal progesterone synthesis, whether presented 
as phospholipid/cholesterol dispersion or as HDL 
(0.07 mg/ml, cf. 0.02 mg/ml). 
A control experiment was needed to determine 
whether or not the stimulation of progesterone 
synthesis by phospholipid/cholesterol dispersions 
(table 1) was due to the cholesterol or to the 
phospholipid component of the dispersions. 
Rather than use a dispersion of phospholipid 
alone, which on available evidence [ 191 might have 
been expected to extract cholesterol from the luteal 
cells and consequently make the cells fragile to the 
point of lysis, we prepared dispersions from 
phospholipid and sterols other than cholesterol, on 
the grounds that these other sterols would largely 
fulfil any relevant structural function performed 
by cholesterol in the lipid dispersions, but would 
be unacceptable to the luteal cells as substrates for 
progesterone synthesis. Table 2 demonstrates that 
none of the dispersions tested, other than the one 
containing cholesterol as its sterol component, 
could enhance luteal cell progesterone synthesis. It 
is also apparent from the data of table 2 that the 
presence of delipidated HDL-apoproteins in the 
sterol/phospholipid dispersions had no ap- 
preciable effect upon the efficiency of exogenous 
sterol utilization. 
It is- necessary to comment upon an apparent 
discrepancy between the results described above 
and those reported in [20] which indicated that a 
phospholipid/cholesterol dispersion was ineffec- 
tive in stimulating luteal cell progesterone forma- 
tion. The experimental conditions reported above 
are not comparable with those of the study de- 
scribed in [20] in which the rats were not treated 
with 4-APP and lutropin was absent from the cell 
incubation medium. We have shown previously 
that, whereas HDL was able to stimulate pro- 
gesterone synthesis by luteal cells from rats treated 
with 4-APP, HDL did not significantly affect pro- 
gesterone synthesis by luteal cells from rats which 
had not been treated with 4-APP [3]. We also 
I ’ I t 
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phospholipid/cholesterol dispersion 
Fig.1. The effect of increasing concentrations of 
cholesterol, presented as phospholipid/cholesterol 
dispersion, upon progesterone synthesis by luteal cells 
from rats treated with 4-APP. Experimental conditions 
were as described in the legend to table 1 except hat the 
amount of phospholipid/cholesterol dispersion was 
varied so as to give the concentrations shown on the 
graph. Lutropin was present in all incubations at 
200 ng/ml. The amount of progesterone formed in the 
presence of lutropin but in the absence of 
phospholipid/cholesterol dispersion was subtracted 
from that formed in all other incubations. 
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Table 2 
Effect of various sterols on progesterone synthesis by 
luteal cells isolated from rats treated with 4-APP 
Present during incubation Progesterone formed 
(ng/106 cells per 2 h) 
Lutropin 
Lutropin + phospholipid/ 
(a) (b) 
447 (14.1) 368 (17.1) 
dihydrocholesterol 
Lutropin + phospholipid/ 
450 (14.7) 360 (16.7) 
&sitosterol 461 (15.1) 383 (17.8) 
Lutropin + phospholipid/ 
ergosterol 
Lutropin + phospholipid/ 
437 (14.3) 346 (16.1) 
cholesterol 2794 (91.5) 1891 (87.9) 
Lutropin + HDL 3053 (100) 2151 (100) 
Experimental conditions were as described in the legend 
to table 1. The phospholipid/sterol dispersions were 
prepared as described in section 2. (a) and (b) refer to 
two separate experiments using different cell 
preparations. In (b), lipid-free HDL apoproteins 
(prepared as described in section 2) were incorporated 
into the lipid dispersions at a concentration of 5 mg/ml, 
by adding the HDL-apoproteins to the dispersions and 
sonicating for a further 2 min. Numbers in parentheses 
are the % yields of progesterone in each experiment, 
relative to that produced in the presence of lutropin + 
HDL (100%) 
showed that added lipoprotein had no significant 
effect on luteal cell progesterone synthesis unless 
lutropin was also present during the incubation of 
the cells [3]. It is also well known that luteal cells, 
incubated in the absence of lutropin, synthesize 
only about one-tenth of the progesterone which 
they can make in its presence [l I]. A significant 
stimulation of progesterone synthesis by lipopro- 
teins or phospholipid/cholesterol dispersions 
would not, therefore, be expected under the ex- 
perimental conditions reported in [20]. 
In view of recent reports that (i) the association 
of HDL with aortic endothelial cells and muscle 
cells and with skin fibroblasts can occur via the in- 
teraction of cell surface- and HDL surface-lipids 
[21] and (ii) the delivery of cholesterol from HDL 
to rat ovary cells is not strictly dependent upon the 
presence of a specific apolipoprotein [lo] it is in- 
teresting that we have shown a protein-free disper- 
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sion of cholesterol and phospholipid to be able to 
increase lutropin-stimulated luteal cell pro- 
gesterone synthesis to the same level as that given 
by HDL (tables 1,2) and that HDL-apoproteins, 
when incorporated into such dispersions, have no 
demonstrable ffect upon, the yield of progesterone 
(table 2). It is not possible at present, however, to 
know whether or not the lipid dispersion acts via 
the same mechanism as that by which HDL func- 
tions in progesterone synthesis. 
The data that we have presented provide the on- 
ly direct evidence to support the view that it is the 
cholesterol component of HDL upon which the rat 
corpus luteum depends for its ability to synthesize 
progesterone. 
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